Joji Suzuki
Program Director · Mass General Brigham
Credentials: · · · · ·
History
Research
A review: Fentanyl and non-pharmaceutical fentanyls
Review · Drug and Alcohol Dependence · 2017 · First of 2 authors · Corresponding · 298 citations
Journal of Clinical Oncology · 2018 · 146 citations
Review · Open Forum Infectious Diseases · 2018 · First of 5 authors · Corresponding · 121 citations
11 papers
- CP
8 papers
Peter Chai
8 papers
- DH
6 papers
6 papers
- SA
6 papers · 2 as a fellow
- CR
5 papers
5 papers
Grants
- 2026–2028
Safety and Preliminary Efficacy of Ibogaine as a Treatment for Opioid Use Disorder
National Institute on Drug Abuse · UG3
Contact PI · $2.3M · Brigham and Women's Hospital
- 2024–2027
Semaglutide for the Treatment of Opioid Use Disorder: A Pilot Randomized Controlled Trial
National Institute on Drug Abuse · R21
Contact PI · $492.3K · Brigham and Women's Hospital
- 2024–2027
Extended Release Buprenorphine as a Novel Low-Dose Induction Strategy
National Institute on Drug Abuse · R21
Contact PI · $496.3K · Brigham and Women's Hospital
- 2023–2025
Oral Complications from Sublingual Buprenorphine Treatment: A Prospective Cohort Study
National Institute of Dental and Craniofacial Research · R21
Contact PI · $419.8K · Brigham and Women's Hospital
Clinical trials
- 2026–2030
Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder
Principal investigator · Not yet recruiting · Phase 2
Brigham and Women's Hospital
- 2026–2028
Tirzepatide for the Treatment of Cannabis Use Disorder
Principal investigator · Not yet recruiting · Phase 2
Brigham and Women's Hospital
- 2025–2026
Targeted Naltrexone to Support Individuals Participating in Dry January
Principal investigator · Completed · Phase 2
Brigham and Women's Hospital
- 2025–2027
Study of Tirzepatide for Recovery and Alcohol Use Management
Principal investigator · Recruiting · Phase 2
Brigham and Women's Hospital